Blacks, Asians at Higher Risk for Allopurinol-Related Skin Reactions

Posted on Posted in Uncategorized, Zyloprim and Allopurinol

By Deborah Levenson Be careful when prescribing allo¬purinol to black and Asian gout patients, a study newly advises. Black and Asian patients who take this ubiquitous, more-than-40-year-old medication are at much higher risk of certain serious skin reactions than are Caucasians or Hispanics. Compared with Caucasians, blacks who take allopurinol to lower blood urate levels […]

Sanofi, GlaxoSmithKline Disclose DOJ Investigation Into Zantac After Recalls

Posted on Posted in Zantac

After global recalls of heartburn medicine Zantac and an FDA ban, the Department of Justice is investigating Sanofi and GlaxoSmithKline for possible violations of the False Claims Act. The drugmakers last year pulled their Zantac products over an impurity believed to cause cancer, and Sanofi said the probe is over disclosures relating to that impurity. GSK didn’t comment on the […]

FDA Uloric Warning Renews Concerns over Older Gout Drug Allopurinol

Posted on Posted in Zyloprim and Allopurinol

Terry Turner, Drugwatch The number of people taking the gout medication allopurinol has been rising as gout becomes more prevalent. Prescriptions also got a boost after the U.S. Food and Drug Administration limited the use of Uloric (febuxostat) in 2019, effectively leaving allopurinol as the primary first-line medication option for gout patients. But at the […]

Johnson & Johnson’s $100 Million Baby Powder Lawsuit Settlement Is Overdue For Black & Hispanic Women

Posted on Posted in Talcum Powder Cancer Link

Forbes, Kori Hale Facing almost 20,000 lawsuits by women who blame  Johnson & Johnson’s talcum powder for causing cancer finally has a $100 million settlement from the manufacturer. The company agreed to settle 1,000 of these cases in bulk. Despite growing concerns of carcinogenic agents, the products giant continued to market and sell its baby […]

Gout Flare Common Following Allopurinol Discontinuation

Posted on Posted in Zyloprim and Allopurinol

It is necessary to continue urate-lowering therapy in the inpatient setting to decrease the risk of gout flare in hospitalized patients.   Gout flare is almost 14-times more likely to develop in hospitalized patients who have allopurinol discontinued upon admission compared to those who have the treatment continued, according to new study findings. The findings, presented […]

DeLauro Demands Johnson & Johnson Recall Talc-Based Baby Powder, Criticizes Company’s Past Marketing Targeting Women of Color

Posted on Posted in Talcum Powder Cancer Link

September 16, 2020 Press Release DeLauro in a letter to CEO Gorsky: “By concealing any notion of potential asbestos contamination of its baby powder, Johnson & Johnson violated that trust and placed millions of lives at risk.” As a survivor, DeLauro marks Ovarian Cancer Awareness Month with a call on Johnson & Johnson to remove […]